Navigation Links
Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee
Date:10/22/2008

rovide relief from pain for up to six months. This treatment is injected directly into the knee joint over the course of three visits, each one week apart.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. Genzyme has been selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Important Safety Information

SYNVISC is used to relieve knee pain due to osteoarthritis (OA). It is for patients who do not get enough relief from simple painkillers such as acetaminophen, or from exercise and physical therapy.

SYNVISC is generally well tolerated. However, it may not work for everyone. The side effects most commonly seen when SYNVISC is injected into the knee were pain, swelling and/or fluid buildup around the knee. Cases where the swelling is extensive or painful should be discussed with your doctor. Other side effects such as rash have been reported rarely. Before trying SYNVISC, tell your doctor if you are allergic to products from birds - such as feathers, eggs or poultry - or if your leg is swollen or infected. Talk to your doctor before resuming strenuous weight-bearing
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
5. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
6. Roche to Nominate Independent Directors for Election at Ventanas 2008 Annual Stockholders Meeting
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R)
8. Kiwa Fertilizers Pass Independent Tests
9. Amarin Appoints Dr. William Mason as Lead Independent Director
10. China Pharma Appoints Three Independent Non-Executive Directors
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 News Facts ... devoted to genome-based research for human health and ... is taking a bite out of oral cancer with its ... India with the help of state-of-the-art ... Networks (DDN). , To fuel its cutting-edge cancer research, ...
(Date:9/23/2014)... 23, 2014 Cambridge Semantics, the leading ... technology, was named in the recent ‘Hype Cycle for ... , The report details key insights pertaining to the ... to Gartner analysts Michael Shanler and Stephen Davies, “The ... expose complex relationships with scientific stakeholders, and support collaboration ...
(Date:9/23/2014)... Texas Fertility Center (TFC) announces the opening ... a Central Texas footprint that includes Round Rock, Central ... for the region’s most established practice will provide full ... Buda, Kyle and San Marcos communities. , “We ... to individuals and couples living in and around South ...
(Date:9/23/2014)... 23, 2014 Healthcare professionals, ... will convene at the Society for Integrative ... held October 26-28 in Houston, Texas to ... practice in individualized integrative cancer care. This ... psychologists, nutritionists, naturopaths, acupuncturists, and other complementary ...
Breaking Biology Technology:National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today reported ... ended May 31, 2008. All dollar amounts referenced,herein are ... 31, 2008, our cash and cash equivalents totaled $12.4 ... The net loss for the second quarter of 2008 ...
... of Coronary Artery Disease ... Patients in Real-World Setting, ABBOTT PARK, Ill., July ... post-approval study, with six,hospital centers already recruiting and enrolling patients just ... V(TM),Everolimus Eluting Coronary Stent System. The XIENCE V USA study will,evaluate ...
... 9 Abt Bio-Pharma Solutions, Inc.,(ABS), a ... and,strategic commercialization solutions, is pleased to announce ... business strategy, has been promoted to,Executive Director ... Susan Windham-Bannister, who has been appointed,President & ...
Cached Biology Technology:Vasogen Announces Second Quarter 2008 Results 2Vasogen Announces Second Quarter 2008 Results 3Vasogen Announces Second Quarter 2008 Results 4Vasogen Announces Second Quarter 2008 Results 5Vasogen Announces Second Quarter 2008 Results 6Vasogen Announces Second Quarter 2008 Results 7Vasogen Announces Second Quarter 2008 Results 8Vasogen Announces Second Quarter 2008 Results 9Vasogen Announces Second Quarter 2008 Results 10Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent 2Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent 3Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent 4Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister 2Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister 3
(Date:9/22/2014)... Scientists have discovered a key molecular cog in a ... of circadian (daily) rhythms based on temperature. , Transcription ... based on external stresses such as light, rain, ... team of researchers at USC has isolated one, called ... here and there as needed while in keeping it ...
(Date:9/22/2014)... NEW YORK CITY (September 22, 2014)The Brain ... the award of NARSAD Young Investigator ... to 200 of the world,s most promising ... grants for groundbreaking neurobiological research will seek ... prevention strategies for psychiatric disorders that affect ...
(Date:9/22/2014)... have occurred in the wake of the huge King ... Forest. The King Fire is burning in steep ... Canyon, Silver Creek Canyon, and the Rubicon Canyon, north ... crossed into Placer County and burned onto the Tahoe ... anticipated spread is expected to be minimal on Sept. ...
Breaking Biology News(10 mins):Genetic switch regulates a plant's internal clock based on temperature 2Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2
... for a boat ride or even taken a drink from the ... how valuable? That,s always been a tough question for policy makers ... societal needs that compromise it, such as the need to grow ... so has been greatly enhanced by a new policy-making framework developed ...
... that there are 1.7 million species of animals, plants ... be discovered. Unfortunately, as new species are found, many ... biodiversity. The more diversity there is in a population, ... is key to ecosystem resilience. Disease, destruction of ...
... and decisions to use "least toxic pesticides" and "pesticides ... decade, but according to three scientific organizations the ... Society (APS) and the Plant-Insect Ecosystems Section of the ... not the correct approaches to the pesticide component of ...
Cached Biology News:Study offers new tool for incorporating water impacts into policy decisions 2Persistence or extinction: Through a mathematical lens 2Persistence or extinction: Through a mathematical lens 3Scientists take objective look at terms 'least toxic pesticides' applied as 'last resort' 2Scientists take objective look at terms 'least toxic pesticides' applied as 'last resort' 3Scientists take objective look at terms 'least toxic pesticides' applied as 'last resort' 4Scientists take objective look at terms 'least toxic pesticides' applied as 'last resort' 5